Log in

Risk factors for pneumonia among children with coinfection of influenza A virus and Mycoplasma pneumoniae

  • Research
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Objective

To investigate the clinical characteristics and risk factors for pneumonia in children co-infected with influenza A virus (IAV) and Mycoplasma pneumoniae (MP).

Methods

Children who were diagnosed with IAV and MP infection between January and December, 2023 were enrolled and divided into a non-pneumonia group and a pneumonia group. Univariate analysis and logistic regression analysis were used to evaluate each index, and the risk factors for pneumonia caused by coinfection in the two groups were explored.

Results

A total of 209 patients were enrolled, of which 107 and 102 patients were in the pneumonia and non-pneumonia groups, respectively. The patients in the pneumonia group were older and had a longer duration of fever (P < 0.05). Univariate analysis revealed that the median age, duration of fever, and CD3+, CD4+, CD8+ and IL-10 levels were significantly correlated with pneumonia (P < 0.05). Multivariate logistic regression analysis revealed that the median age, duration of fever, and CD4+, CD8+ and IL-10 levels were independent risk factors for pneumonia. Area under the curve of the five combined indicators in the ROC (receiver operator characteristic) analysis was 0.883, was higher than single factor.

Conclusion

Children with IAV and MP infection whose age older than 6.08 years, had a fever longer than 4 days, had a CD4+ count < 22.12%, had a CD8+ count < 35.21%, had an IL-10 concentration > 22.08 ng/ml were more likely to develop pneumonia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data Availability

The datasets generated during and/or analysed during the current study are not publicly available due to privacy requirements but are available from the corresponding author on reasonable request.

References

  1. Liu B et al (2016) The C-terminal tail of TRIM56 dictates antiviral restriction of influenza A and B viruses by impeding viral RNA synthesis. J Virol 90(9):4369–4382

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. LeMessurier KS et al (2020) Influenza A virus directly modulates mouse eosinophil responses. J Leukoc Biol 108(1):151–168

    Article  CAS  PubMed  Google Scholar 

  3. Le Goffic R et al (2007) Cutting edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 178(6):3368–3372

    Article  PubMed  Google Scholar 

  4. Shen Y et al (2012) TRIM56 is an essential component of the TLR3 antiviral signaling pathway. J Biol Chem 287(43):36404–36413

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Liu BM et al (2024) Key roles for phosphorylation and the Coiled-coil domain in TRIM56-mediated positive regulation of TLR3-TRIF-dependent innate immunity. J Biol Chem 300(5):107249

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Hu Q et al (2023) Risk factors for death associated with severe influenza in children and the impact of the COVID-19 pandemic on clinical characteristics. Front Pediatr 11:1249058

    Article  PubMed  PubMed Central  Google Scholar 

  7. Trusinska D. et al. (2024) Risk factors for poor outcomes in children hospitalized with virus-associated acute lower respiratory infections: a systematic review and meta-analysis. Pediatr Infect Dis J 2024 May 1;43(5):467–476

  8. Mingyue J, Luzhao F (2023) Consideration on the usage of full-dose influenza vaccine for the infants aged 6–35 months old. Chin J Prev Med 57(2):281–285

    Google Scholar 

  9. Huang H, Wu B, Lin W (2024) Characterising respiratory infections among hospitalised children during the COVID-19 pandemic in southeastern China: a cross-sectional study of pathogens and clinical association. BMJ Open 14(1):e076824

    Article  PubMed  PubMed Central  Google Scholar 

  10. Chengbo Z, Wenbo L (2022) Analysis of non-bacterial respiratory pathogens in children in Ningbo City from 2019 to 2021. Chin J Prev Med 56(12):1751–1758

    Google Scholar 

  11. Sakleshpur S, Steed AL (2022) Influenza: Toward understanding the immune response in the young. Front Pediatr 10:953150

    Article  PubMed  PubMed Central  Google Scholar 

  12. Control, E.C.f.D.P.a. Acute respiratory infections in the EU/EEA: epidemiological update and current public health recommendations. Infectious disease topics 2023; Available from: https://www.ecdc.europa.eu/en/news-events/acute-respiratory-infections-eueea-epidemiological-update-and-current-public-health

  13. Looi MK (2023) China: Rising cases of respiratory disease and pneumonia spark WHO concern. BMJ 383:2770

    Article  PubMed  Google Scholar 

  14. Parums DV (2023) Editorial: Outbreaks of post-pandemic childhood pneumonia and the re-emergence of endemic respiratory infections. Med Sci Monit 29:e943312

    Article  PubMed  PubMed Central  Google Scholar 

  15. China National Clinical Research Center for Respiratory DiseasesGroup of Respirology C.P.S. and C.M. Association (2020) Expert consensus on diagnosis and treatment of influenza in children (2020 Edition). Chin J Pract Pediatr Clin 35(17):1281–1288

    Google Scholar 

  16. Children’s Medication Group E.C.f.R.D.U (2020) National health and family planning commission, Expert consensus on laboratory diagnostics and clinical practice of Mycoplasma pneumoniae infection in children in China (2019). Chin J Pediatr 58(5):366–373

    Google Scholar 

  17. Subspecialty Group of Respiratory Diseases S.o.P., Chinese Medical Association and E.B.o.C.J.o. Pediatrics (2013) Guidelines for the management of community-acquired pneumonia in children (2013 revision)(Part 1). Chin J Pediatr 51(10):745–752

    Google Scholar 

  18. Frutos AM et al (2024) Interim estimates of 2023–24 seasonal influenza vaccine effectiveness - United States. MMWR Morb Mortal Wkly Rep 73(8):168–174

    Article  PubMed  PubMed Central  Google Scholar 

  19. Abraham C et al (2023) Vaccine mandates and influenza vaccination during the pandemic. Pediatrics 152(5)

  20. Diseases NCRCfR, SGoR Diseases (2020) Pediatric initiative on improving uptake of seasonal influenza vaccination among children during the COVID 一19 pandemic. Chin J Pract Pediatr Clin 35(17):1289–1291

    Google Scholar 

  21. Paniskaki K et al (2023) Increased SARS-CoV-2 reactive low avidity T cells producing inflammatory cytokines in pediatric post-acute COVID-19 sequelae (PASC). Pediatr Allergy Immunol 34(12):e14060

    Article  PubMed  Google Scholar 

  22. Liu S et al (2013) MCPIP1 restricts HIV infection and is rapidly degraded in activated CD4+ T cells. Proc Natl Acad Sci U S A 110(47):19083–19088

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Liu BM et al (2024) Mpox (Monkeypox) Virus and Its Co-infection with HIV, sexually transmitted infections, or bacterial superinfections: Double whammy or a new prime culprit? Viruses 16(5):784

    Article  Google Scholar 

  24. Santiago-Carvalho I et al (2023) T cell-specific P2RX7 favors lung parenchymal CD4(+) T cell accumulation in response to severe lung infections. Cell Rep 42(11):113448

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Medzhitov R, Schneider DS, Soares MP (2012) Disease tolerance as a defense strategy. Science 335(6071):936–941

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Fang W, Boliang Z (2014) Detection and analysis of peripheral blood T lymphocyte subsets in patients with influenza A (H1N1). Int J Lab Med 7:922–923

    Google Scholar 

  27. Ding L et al (2016) Association of T lymphocyte subsets and allergens with Mycoplasma pneumoniae infection complicated by wheezing in infants and young children. Zhongguo Dang Dai Er Ke Za Zhi 18(12):1254–1258

    PubMed  Google Scholar 

  28. Liu BM et al (2021) Clinical significance of measuring serum cytokine levels as inflammatory biomarkers in adult and pediatric COVID-19 cases: A review. Cytokine 142:155478

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Liu BM, Hill HR (2020) Role of host immune and inflammatory responses in COVID-19 cases with underlying primary immunodeficiency: A review. J Interferon Cytokine Res 40(12):549–554

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Liu BM, Beck EM, Fisher MA (2021) The brief case: ventilator-associated corynebacterium accolens pneumonia in a patient with respiratory failure due to COVID-19. J Clin Microbiol 59(9):e0013721

    Article  PubMed  Google Scholar 

  31. Saraiva M, P Vieira, A O'Garra (2020) Biology and therapeutic potential of interleukin-10. J Exp Med 217(1)

  32. Neumann C, Scheffold A, Rutz S (2019) Functions and regulation of T cell-derived interleukin-10. Semin Immunol 44:101344

    Article  CAS  PubMed  Google Scholar 

  33. Rojas JM et al (2017) IL-10: A multifunctional cytokine in viral infections. J Immunol Res 2017:6104054

    Article  PubMed  PubMed Central  Google Scholar 

  34. Choreño-Parra JA et al (2021) Clinical and immunological factors that distinguish COVID-19 from pandemic influenza A(H1N1). Front Immunol 12:593595

    Article  PubMed  PubMed Central  Google Scholar 

  35. Kim JH et al (2018) Clinical features of Mycoplasma pneumoniae coinfection and need for its testing in influenza pneumonia patients. J Thorac Dis 10(11):6118–6127

    Article  PubMed  PubMed Central  Google Scholar 

  36. Liu B, Forman M, Valsamakis A (2019) Optimization and evaluation of a novel real-time RT-PCR test for detection of parechovirus in cerebrospinal fluid. J Virol Methods 272:113690

    Article  CAS  PubMed  Google Scholar 

  37. Liu B (2017) Universal PCR primers are critical for direct sequencing-based enterovirus genoty**. J Clin Microbiol 55(1):339–340

    Article  PubMed  Google Scholar 

  38. Liu B et al (2020) Development and evaluation of a fully automated molecular assay targeting the mitochondrial small subunit rRNA gene for the detection of pneumocystis jirovecii in bronchoalveolar lavage fluid specimens. J Mol Diagn 22(12):1482–1493

    Article  CAS  PubMed  Google Scholar 

  39. Liu BM et al (2024) Laboratory diagnosis of CNS infections in children due to emerging and re-emerging neurotropic viruses. Pediatr Res 95(2):543–550

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Henan Provincial Science and Technology Research Project [grant numbers LHGJ20200620, LHGJ20220734] and by 2023 Open Subjects of Henan Provincial Engineering Research Center for Diagnosis and Treatment of Pediatric Infections and Critical Illnesses [China] [grant number ERC202304].

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Wanyu Jia, Yangji Wang, and Junhao Cui. The first draft of the manuscript was written by Shuqin Fu. Peng Li and Chunlan Song conceptualized the study and reviewed and edited the manuscript. All authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Chunlan Song.

Ethics declarations

Ethics approval and consent to participate

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Medical Ethics Committee of Henan Children’s Hospital (approval number: [2022-K-L046]).

Consent to participate

This is a retrospective study, so informed consent was waived.

Competing interests

The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fu, S., Jia, W., Li, P. et al. Risk factors for pneumonia among children with coinfection of influenza A virus and Mycoplasma pneumoniae. Eur J Clin Microbiol Infect Dis (2024). https://doi.org/10.1007/s10096-024-04854-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10096-024-04854-3

Keywords

Navigation